John Ayodele OLANIYI, Olatubosun Ganiyu ARINOLA

Nitric oxide and trace metals in relation to haemoglobin F concentration in Nigerian sickle cell disease patients

Sickle cell disease (SCD) is an inherited haemoglobin (Hb) disorder associated with vaso-occlusive events, oxidative stress, high energy demand, and endothelial dysfunction. The endothelium plays a central role in the regulation of vascular homeostasis by releasing nitric oxide (NO) among other factors. Therefore, the objective of this study was to measure plasma levels of NO, trace metals, and HbF in SCD patients. Materials and methods: Plasma levels of NO, Zn, Mg, Mn, Se, Cu, Fe, Haemoglobin F (HbF) were measured in 59 steady state SCD patients referred to the Department of Haematology, University College Hospital, Ibadan, Nigeria and 35 age/sex matched controls using Griess reagents and spectrophotometry. Results: Mean levels of HbF, NO, and Zn were significantly elevated while the levels of Fe, Cr, and Se were significantly reduced in SCD patients compared with the controls. In SCD patients, HbF showed significant negative correlations with Fe, Mn, Cr, and Se. Also in SCD patients, HbF showed significant positive correlation with NO. Conclusion: Nutritional supplements that will increase certain essential trace metals but will reduce NO and oxidants may be tested in the management of SCD patients.

Anahtar Kelimeler:

Key words: Sickle cell disease, trace metals, haemoglobin F, oxidants

Nitric oxide and trace metals in relation to haemoglobin F concentration in Nigerian sickle cell disease patients

Keywords:

Key words: Sickle cell disease, trace metals, haemoglobin F, oxidants,

PDF

___

Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med 1999; 337: 762-769.
Das AK. A text book of Medicinal plants of bio-inorganic chemistry. 1st Edition CBS publishers and Distribution pp5-9.
Schnog JB Duitz AJ, Muskiet FAJ, Tengate H, Roger RA, Brandjes DPM. Sickle cell disease: A general Review. Netherlands J Med 2004; 62: 364-369.
Anderson RA. Chromium glucose intolerance and diabetes. J Amer Coll Nutr 1998; 17: 548-555.
Bendich A. Antioxidant micronutients and immune responses. Annal N Y Acad Scs 1990; 587; 168-180.
Osarogiagbon RU. Newer concepts in the Pathogenesis of sickle cell disorder: The evidence for inflammation. Arch Ibadan Med. 2001; 2: 41-45.
Asia N, Ryan M, Adler B. Oxygen radical inhibition of Nitric oxide-dependent vascular function in sickle cell disease. Pro Nat Acad Sci 2001. 44: 223-228.
Ebarhardt RT, MacMahon L, Duffy JJ, Sternberg MH, Perring SP, Loscalzo J, Coffman JD, Vita JA. Sickle cell anaemia is associated with reduced nitric oxide in peripheral conduit and resistance vessels. Amer J Haematol 2003; 74: 104-111.
Hebbel RP. Adhesive interaction of sickle cell erythrocytes with endothelium. J Clin Invest 1997; 100(11 suppl): 583-586.
Moncada S, Higgs A. The L arginine nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012.
Anand IS, Chandrsshekhar Y, Wander GS, Chawla LS. Endothelium derived relaxing factor is important in mediating the high output state in chronic severe anaemia. J Amer Coll Cardiol. 1995; 25: 1402-1407.
Sergient GR, Serjient BE. The epidemiology of sickle cell disorder: A challenge for Africa. Arch Ibadan Medicine. 2001; 2: 46-51.